Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells

por Nishikubo, Kou, Ohgaki, Ryuichi, Liu, Xingming, Okanishi, Hiroki, Xu, Minhui, Endou, Hitoshi, Kanai, Yoshikatsu
Publicado 2023

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells

por Nishikubo, Kou, Ohgaki, Ryuichi, Okanishi, Hiroki, Okuda, Suguru, Xu, Minhui, Endou, Hitoshi, Kanai, Yoshikatsu
Publicado 2022

A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy

por Jimbo, Keisuke, Okuno, Toshiaki, Ohgaki, Ryuichi, Nishikubo, Kou, Kitamura, Yuri, Sakurai, Yumiko, Quan, Lili, Shoji, Hiromichi, Kanai, Yoshikatsu, Shimizu, Toshiaki, Yokomizo, Takehiko
Publicado 2020

Correction: A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy

por Jimbo, Keisuke, Okuno, Toshiaki, Ohgaki, Ryuichi, Nishikubo, Kou, Kitamura, Yuri, Sakurai, Yumiko, Quan, Lili, Shoji, Hiromichi, Kanai, Yoshikatsu, Shimizu, Toshiaki, Yokomizo, Takehiko
Publicado 2021